OTCMKTS:GSTC GlobeStar Therapeutics - GSTC Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding GlobeStar Therapeutics Co. Please log in to your account or sign up in order to add this asset to your watchlist. $0.0087 0.00 (0.00%) (As of 02/3/2023 12:00 AM ET) Add Compare Share Share Today's Range$0.0061▼$0.009350-Day Range$0.01▼$0.0252-Week Range$0.00▼$0.02Volume2.75 million shsAverage Volume4.27 million shsMarket Capitalization$6.70 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest About GlobeStar Therapeutics (OTCMKTS:GSTC) StockGlobeStar Therapeutics Corp. is a clinical stage biotechnology company, which engages in the manufacture and patented formulation of previously approved drugs for the treatment of Multiple Sclerosis. The company was founded by David P. Summers in 2011 and is headquartered in Richland, WA.Read More Receive GSTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GlobeStar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address GSTC Stock News HeadlinesJanuary 3, 2023 | finance.yahoo.comGlobeStar Therapeutics Corporation (GSTC)November 27, 2022 | reuters.comGlobeStar Therapeutics CorpFebruary 5, 2023 | Tradewins (Ad)Know Your Profit Potential BEFORE You Trade!I’m Chuck Hughes, ten-time trading champion and author of the coveted e-book, “Options Trading Made Easy”, the strategy guide that will teach you to calculate your trade’s profit potential before you risk any capital. Click here for a free copy now! August 2, 2022 | finance.yahoo.comGlobeStar Therapeutics Corporation Update on Recent ActivityMarch 1, 2022 | finance.yahoo.comGlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking ContractMarch 1, 2022 | finance.yahoo.comCORRECTING and REPLACING GlobeStar Therapeutics Corporation Awards New York Bay Capital, LLC Investment Banking ContractFebruary 4, 2022 | finance.yahoo.comGlobeStar Therapeutics Corporation Addresses the Potential Link Between Neurodegenerative Disease and Parkinson’s DiseaseJanuary 12, 2022 | nasdaq.comGlobeStar Therapeutics Corp (GSTC)February 5, 2023 | Wall Street Watch Dogs (Ad)“Future Fuel” will unleash $11 trillion wave of wealthThe next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…October 18, 2021 | finance.yahoo.comGlobeStar Therapeutics Corporation To Be Seen In The Washington Football Team Yearbook All SeasonOctober 18, 2021 | finance.yahoo.comGlobeStar Therapeutics Corporation Unveils New Corporate Website and Branding CampaignOctober 18, 2021 | finance.yahoo.comGlobeStar Therapeutics Corporation Files New 8K Statement Focused On Progress, Market Acceptance, And A Potential Game-Changing Drug For Multiple SclerosisOctober 18, 2021 | finance.yahoo.comGlobeStar Therapeutics Corporation Additional Progress Toward A U.S.-Based Clinical Trial.October 18, 2021 | finance.yahoo.comGlobeStar Therapeutics Corporation Has Been Upgraded to the QB Tier on OTC MarketsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive GSTC Stock News and Ratings via Email Sign-up to receive the latest news and ratings for GlobeStar Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address GSTC Company Calendar Today2/05/2023Fiscal Year End9/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS Industry Pharmaceutical preparations Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GSTC CUSIPN/A CIK1502152 Webangiosoma.com Phone(206) 451-1970FaxN/AEmployees1Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-1,490,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-16,688.16% Debt Debt-to-Equity RatioN/A Current Ratio0.01 Quick Ratio0.01 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares770,360,000Free FloatN/AMarket Cap$6.70 million OptionableNot Optionable Beta1.09 Key ExecutivesJames C. KatzaroffChairman, President, CEO & SecretaryRobert ChicoskiChief Financial Officer & TreasurerDavid CroomExecutive Vice PresidentBrooke GreenwaldChief Marketing OfficerKey CompetitorsNeuroBo PharmaceuticalsNASDAQ:NRBOPainReformNASDAQ:PRFXHelix BioMedixOTCMKTS:HXBMPetros PharmaceuticalsNASDAQ:PTPISonoma PharmaceuticalsNASDAQ:SNOAView All Competitors GSTC Stock - Frequently Asked Questions How have GSTC shares performed in 2023? GlobeStar Therapeutics' stock was trading at $0.0133 at the start of the year. Since then, GSTC stock has decreased by 34.6% and is now trading at $0.0087. View the best growth stocks for 2023 here. Are investors shorting GlobeStar Therapeutics? GlobeStar Therapeutics saw a increase in short interest in December. As of December 30th, there was short interest totaling 168,600 shares, an increase of 143.6% from the December 15th total of 69,200 shares. Based on an average trading volume of 18,869,100 shares, the days-to-cover ratio is presently 0.0 days. View GlobeStar Therapeutics' Short Interest. What is GlobeStar Therapeutics' stock symbol? GlobeStar Therapeutics trades on the OTCMKTS under the ticker symbol "GSTC." How do I buy shares of GlobeStar Therapeutics? Shares of GSTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is GlobeStar Therapeutics' stock price today? One share of GSTC stock can currently be purchased for approximately $0.01. How much money does GlobeStar Therapeutics make? GlobeStar Therapeutics (OTCMKTS:GSTC) has a market capitalization of $6.70 million. How can I contact GlobeStar Therapeutics? GlobeStar Therapeutics' mailing address is 2500 WILCREST DRIVE 3RD FLOOR, HOUSTON TX, 77042. The official website for the company is angiosoma.com. The company can be reached via phone at (206) 451-1970 or via email at investors@angiosoma.info. This page (OTCMKTS:GSTC) was last updated on 2/5/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.